150 Participants Needed

Supervised Exercise for Single Ventricle Heart Condition

ST
Overseen BySeda Tierney
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how a supervised exercise program can benefit children with a single-ventricle heart condition, specifically those who have undergone the Fontan procedure. The goal is to determine if regular, guided exercise can improve heart and physical health, boost muscle strength, and support better blood vessel function. Participants will either begin the Live-Video-Supervised Exercise Intervention immediately or after a period of usual care. This trial suits children and teens aged 8 to 19 who have had the Fontan procedure and can safely exercise.

As an unphased trial, this study provides a unique opportunity for participants to contribute to valuable research that could enhance care for future patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this exercise intervention is safe for children with single ventricle heart conditions?

Research has shown that exercising with live video supervision is generally safe for people with heart conditions, including children and teens with congenital heart issues. Studies have found that this type of exercise can enhance heart and physical fitness, muscle strength, and overall health without major safety concerns. Specifically, for children with single ventricle heart conditions, interactive telehealth programs like this exercise plan have been linked to fewer problems and reduced need for emergency care. Overall, live-video-supervised exercise is well-tolerated and considered safe for children with similar heart conditions.12345

Why are researchers excited about this trial?

Researchers are excited about the live-video-supervised exercise intervention for single ventricle heart conditions because it introduces a novel delivery method that allows patients to engage in supervised exercise sessions remotely. This approach contrasts with the standard of care, which typically involves physical therapy or unsupervised exercise. The live video format provides consistent guidance and monitoring, potentially increasing adherence to exercise routines. Additionally, this intervention aims to empower patients by enabling them to exercise independently with personalized plans, using heart rate monitors for feedback. Overall, this method could lead to improved heart health in a more accessible and flexible way.

What evidence suggests that this live-video-supervised exercise intervention is effective for single ventricle heart condition?

Research has shown that exercise programs can improve health in children with single ventricle heart conditions. In this trial, participants will join one of two groups. One group will start with a Live-Video-Supervised Exercise Intervention, while the other will receive usual care before beginning the exercise intervention. Studies have found that live video-supervised exercise is safe and can enhance exercise ability and muscle growth in young patients with congenital heart disease. These programs have also reduced complications and emergency visits for infants with similar heart issues. Additionally, they have improved muscle strength and overall heart health. This evidence suggests that structured exercise could benefit children with the Fontan circulation, potentially reducing long-term risks.15678

Are You a Good Fit for This Trial?

This trial is for children and teenagers aged 8-19 with a single ventricle heart condition who've had Fontan palliation. They must be able to fast overnight, speak English, have cardiac clearance to exercise, and if under 14, an adult must be present during exercise sessions.

Inclusion Criteria

I am under 14 and will have an adult with me during exercise sessions.
I have undergone the Fontan procedure for heart disease.
I am between 8 and 19 years old.
See 2 more

Exclusion Criteria

I have not been seriously ill in the last 3 months.
I have severe heart failure.
You have a pacemaker implanted.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Exercise Intervention

Participants in the exercise intervention arm will participate in live-video-supervised exercise sessions 3 times a week for 3 months

3 months
Live-video sessions 3 times a week

Maintenance

Participants will continue with a maintenance regimen of live-video-supervised exercise sessions once a week and self-directed exercise twice a week for 6 months

6 months
Live-video sessions once a week, self-directed exercise twice a week

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Live-Video-Supervised Exercise Intervention
  • Usual Care then Live-Video Supervised Exercise Intervention
Trial Overview The study tests whether a live-video-supervised exercise program can improve heart and physical capacity, muscle mass and strength, as well as endothelial function in pediatric patients with the Fontan palliation compared to usual care followed by the intervention.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Live-Video-Supervised Exercise Control ArmExperimental Treatment1 Intervention
Group II: Live Video-Supervised Exercise Intervention ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

The Methodist Hospital Research Institute

Collaborator

Trials
299
Recruited
82,500+

Published Research Related to This Trial

Home-based exercise training is a safe and effective alternative to supervised training for patients with congenital heart disease (CHD), with improvements in exercise capacity and walking distance observed in several studies involving both children and adults.
Despite the benefits, high dropout rates (15%) and a lack of reported compliance in many studies (58%) highlight the challenges in maintaining participation in home-based exercise programs.
Current state of home-based exercise interventions in patients with congenital heart disease: a systematic review.Meyer, M., Brudy, L., García-Cuenllas, L., et al.[2020]
In a study of 28 heart failure patients, those who participated in supervised combined physical training showed significant improvements in functional capacity and quality of life compared to those who followed an unsupervised exercise regimen over 12 weeks.
The trained group also experienced enhancements in left ventricular systolic function, indicating that structured exercise programs can be more beneficial for heart failure patients than standard physician-prescribed exercise.
Impact of a Supervised Twelve-Week Combined Physical Training Program in Heart Failure Patients: A Randomized Trial.Fabri, T., Catai, AM., Ribeiro, FHO., et al.[2022]
A randomized controlled trial involving 169 heart failure patients found that a home-based exercise program combined with specialist nurse care did not significantly improve overall quality of life or heart failure symptoms compared to nurse care alone.
However, the exercise group did show some benefits, including improved generic quality of life and reduced anxiety and depression scores at 6 and 12 months, suggesting that while home-based exercise may not be broadly effective, it can have specific positive effects on mental well-being.
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.Jolly, K., Taylor, RS., Lip, GY., et al.[2021]

Citations

Supervised Exercise for Single Ventricle Heart ConditionResearch shows that live-video-supervised exercise is generally safe for people with heart conditions, including children and adolescents with congenital heart ...
Physical activity modification in youth with congenital heart ...In this article, we review how increasing physical activity in youth with CHD may offer immediate and long-term cardiovascular benefits.
Interactive Telehealth Solutions for Patients With ...It significantly improved outcomes for infants with hypoplastic left heart syndrome and single ventricle disease, reducing complications, emergency department ...
Review Exploring the Promise of Telemedicine Exercise ...In this review, we highlight the existing evidence basis for exercise interventions in youth with CHD, explore the promise of incorporating telemedicine home- ...
Feasibility, Safety, and Efficacy of Pediatric Cardiac ...This randomized controlled trial of pediatric participants with heart disease demonstrated that pediatric cardiac telerehabilitation is feasible ...
Interactive Telehealth Solutions for Patients With ...It significantly improved outcomes for infants with hypoplastic left heart syndrome and single ventricle disease, reducing complications, emergency department ...
RePORT RePORTER - National Institutes of Health (NIH) |Our multidisciplinary team of experts will assess the effectiveness of a live-video-supervised exercise intervention, rigorously designed to maximize adherence ...
Design and rationale of re-energize fontan: Randomized ...A live-video-supervised exercise (aerobic+resistance) intervention will improve cardiac and physical capacity; muscle mass, strength, and function; and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security